The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year.
Andrew A MonteAndrew HopkinsonJessica SabenShelby K SheltonStephen ThorntonAaron SchneirAdam PomerleauRobert G HendricksonAnn M ArensJon B ColeJames ChenowethSpencer MartinAxel AdamsSamuel D BanisterRoy R GeronaPublished in: Addiction (Abingdon, England) (2019)
During its first year of operation, the Psychoactive Surveillance Consortium and Analysis Network captured clinical data on new classes of drugs paired with biological samples over a large geographical area in the United States. Synthetic cannabinoids were the most common new psychoactive drug identified. Synthetic opioids were associated with a high rate of intubation and respiratory acidosis.